Theravance Biopharma, Inc. (TBPH)
17.23
+0.45
(+2.68%)
USD |
NASDAQ |
Apr 17, 16:00
17.20
-0.04
(-0.20%)
After-Hours: 20:00
Theravance Biopharma Free Cash Flow : 238.50M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Integer Holdings Corp. | 105.12M |
| QuidelOrtho Corp. | -83.00M |
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Relmada Therapeutics, Inc. | -45.79M |
| Avalo Therapeutics, Inc. | -51.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.064M |
| Cash from Investing (Quarterly) | 0.588M |
| Cash from Financing (Quarterly) | -1.491M |
| Free Cash Flow Per Share (Quarterly) | -0.1145 |
| Free Cash Flow to Equity (Quarterly) | -36.98M |
| Free Cash Flow to Firm (Quarterly) | -5.585M |
| Free Cash Flow Yield | 26.96% |